The vendor landscape of the global market of hematology diagnostics features a handful of companies collectively accounting for a large share in the overall market, hinting at a largely consolidated vendor landscape, observes Transparency Market Research in a recent report. Companies such as Sysmex Corporation, Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd. command dominance owing to their expansive product portfolios and well-established distribution channels globally.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=Brep_id=8848
To gain a larger hold on the market through more diverse product portfolios as compared to their peers, companies are resorting to strategic partnerships. Case in point is Abbott’s October 2017 acquisition of Alere Inc., a leading diagnostic services and device provider. Other leading companies in the market are Siemens Healthineers, Bio-Rad Laboratories, Inc., Danaher (Beckman Coulter, Inc.), Mindray Medical International Limited, HemoCue AB, and HORIBA, Ltd.
Request for Analysis of COVID19 Impact on Hematology Diagnostics Market –
Pharmaceutical Biotechnology Industry Segment Held a Major Share of the Global PCR Market in 2017
The PCR technique has been found to be useful in pharmaceutical and biotechnology research activities as well as microbial quality testing. The technique is also applied in genetic engineering. Genetic engineering is the key driver for the global PCR market. It is used to identify genes related to certain phenotypes including genetic disorders. Regular testing of the microbial load of raw materials and finished products is an important process in the pharmaceutical biotechnology industry. Sophisticated analytical methods such as Hematology Diagnostics) have been widely applied for quality control analysis in the pharmaceutical sector.
According to the report, the global hematology diagnostics market will exhibit a healthy 5.0% CAGR over the period between 2018 and 2026. The market had a valuation of approximately US$3,495.0 mn in 2017 and is anticipated to rise to a revenue opportunity of US$5,586.4 mn by 2026.
Buy Market Report -
Europe and North America to Remain Leading Revenue Contributors to Global Market
Geographically, the markets in Europe and North America are presently the leading contributors of revenue to the global market, chiefly owing to the high prevalence of blood disorders, high awareness regarding available screening methods for blood-related conditions, and high expenditure on healthcare and wellness. Of the key hematology instruments examined in the report, the segment of hematology analyzers presently accounts for the dominant share in the overall market, thanks to the increased adoption of fully-automated hematology analyzers for more accurate results and reduced turnaround times.
Rising Global Prevalence of Blood Cancer to Drive Need for Effective Diagnostic Measures
The chief factor to have helped the global hematology diagnostics market achieve vast stride in terms of technological advancements and introduction of new product varieties at a steady pace in the recent years is the vast rise in focus on the effective diagnosis of the rising cases of blood disorders in developed as well as developing economies. Studies show that blood cancers such as leukemia, lymphoma, or myeloma affected nearly 172,910 people in the U.S. alone in 2017. Cases diagnosed with these cancers are likely to have held a nearly 10% share in the estimated 1,688,780 new cancer cases diagnosed in the country in 2017.
Ask for Discount:
Moreover, nearly 1,290,773 people are either in the remission form or are living with myeloma, leukemia, or lymphoma in U.S. Increased awareness and understanding regarding these conditions among healthcare professionals as well as patients have also led to the increased adoption of hematology diagnostics devices over the years. Apart from this, the increased adoption of point-of-care-testing methods, technological advancements leading to more accurate results and easy-to-use devices, and the easy availability of a vast range of tests are also likely to drive the hematology diagnostics market. However, the market could face headwinds in the form of low awareness among population in developing economies and the high cost of advanced and automated instruments.
This analysis of the global hematology diagnostics market is based on a recent market research report by Transparency Market Research, titled “Hematology Diagnostics Market (Product Type - Hematology Instruments, Hematology Consumables; End use - Diagnostic Laboratories, Hospitals and Clinics, Academic Institutes - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2018 – 2026.”
Browse more Market Reports:
Thyroid Function Test Market:
Urinary Incontinence Treatment Devices Market:
Smart Insulin Pens Market:
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453